iSchemaView and NeuroLogica have announced a partnership to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom computed tomography (CT) scanners for use in mobile stroke units and intensive care units across the globe.
“We are thrilled to partner with NeuroLogica and its leading mobile CT system at the forefront of mobile stroke unit programs across the country,” said Anil Singhal, worldwide operations at iSchemaView. “In addition, we are excited that our partnership allows the option of RAPID advanced imaging on CereToms in more than 500 intensive care units worldwide.”
The CereTom is an 8-slice mobile CT scanner that delivers high-quality, non-contrast CT, CT angiography and CT perfusion scans in a variety of patient locations. RAPID is the most advanced, fully automated and only clinically proven stroke imaging platform available. It provides intuitive and easily interpretable real-time views of brain perfusion and allows clear visualisation of the cerebral arteries. In conjunction, their speed, ease-of-use and fast results make CereTom and RAPID indispensable tools for mobile stroke units and intensive care units, helping medical teams make life-saving triage, diagnostic and treatment decisions. RAPID is the only brain imaging platform that is FDA-cleared for selecting stroke patients for clot removal, also known as thrombectomy.
“By assessing patients in mobile stroke units equipped with both CereTom and RAPID technologies, we will be able to swiftly identify the right course of action—on site treatment with clot-busting agents or appropriate hospital transport for thrombectomy—thereby optimising outcomes and quality of life,” said David Webster, chief operating officer at NeuroLogica.
Developed by leading stroke experts, RAPID combines unmatched expert features, proprietary algorithms and machine learning to deliver the best-in-class advanced stroke imaging and analysis. RAPID provides hypoperfusion, cerebral blood volume indexes, custom notifications and thresholding—including golden-hour thresholds. Additionally, RAPID is the only system that delivers results to mobile devices in less than 90 seconds, either by mobile app or email.
“This is a new frontier in stroke care. We are bringing state-of-the-art technology directly to patients, no matter where they are. This allows us to make fast, accurate assessments of their clinical status and provide effective treatment directly in the mobile stroke units or transport the patient to the appropriate hospital for expedited clot removal,” said James Grotta, director of the Mobile Stroke Unit Consortium and director of Stroke Research for the Clinical Institute for Research and Innovation at the Memorial Herman–Texas Medical Center.
